Company / Free Cash Flow per Share
ROCKET PHARMACEUTICALS, INC. Free Cash Flow per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$2.03
FY2025
5-year range
-$2.07 / -$1.44
FY2021-FY2025
Trend
+2.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share returned to growth in FY2025 after 4 years of decline, reaching $-2.03.
Based on SEC 10-K filings.
-2.03 in FY2025.
Declined from $-1.63 to $-2.03 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow per share increased 2.0% year-over-year.
- Peak free cash flow per share was recorded in FY2018.
- Lowest free cash flow per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.68 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.03 | +2.0% |
| FY2024 | -$2.07 | -26.9% |
| FY2023 | -$1.63 | -10.2% |
| FY2022 | -$1.48 | -2.4% |
| FY2021 | -$1.44 | -42.9% |
| FY2020 | -$1.01 | +17.6% |
| FY2019 | -$1.22 | -42.4% |
| FY2018 | -$0.86 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026